🇺🇸 FDA
Pipeline program

etrasimod

STUDY-25-01158

Phase 2 small_molecule active

Quick answer

etrasimod for Pouchitis is a Phase 2 program (small_molecule) at MAIA Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
MAIA Biotechnology
Indication
Pouchitis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials